跳至主要內容

立法會通過修訂專業會計師條例

立法會今日通過《2022年專業會計師(修訂)條例草案》,優化香港會計師公會理事會選舉安排及公會的行政程序,財經事務及庫務局局長許正宇表示歡迎。   修訂後的《專業會計師條例》提升公會理事會選舉的提名門檻,候選人須取得的會計師提名數目由現時兩名增至十名,並新增候選人須取得兩名會計及財務匯報局諮詢委員會成員附議提名的要求。   修訂條例也統一全部14名當選理事的選舉周期為每兩年改選一次,以及完善公會舉辦理事會選舉和大會的行政程序。   許正宇說,修訂條例確保公會機構管治穩健,並在會財局與公會之間建立緊密聯繫,讓該會有效履行在新會計專業規管制度下的各項職能,從而促進業界長遠發展。   修訂條例11月1日生效。根據過渡安排,公會理事會14名現任當選理事的任期2023年年底結束。經優化的選舉安排將在屆時舉行的理事會選舉適用。
http://dlvr.it/STsn77

此網誌的熱門文章

香港 Backlinks 網站, 中文本地 SEO 必備

市面上的 Backlinks 多數來自外國英文網站,對於香港網站未能精準地改善中文版 Google 排名,有見及此,有 IT 公司推出為香港公司而設的繁體中文 Backlinks 服務,在 100 多個高誠信度的新聞網站刊登文案,增加香港 Backlinks ,大大提升中文版 Google 排名。 新聞網站包括: https://www.buyinghongkong.com https://www.eatinghongkong.com https://www.playinghongkong.com https://www.relaxhongkong.com https://www.hk-bfn.com https://www.hk-cln.com https://www.hk-swn.com https://www.biznews.org.hk https://www.building.org.hk https://www.citylife.org.hk https://www.educate.org.hk https://www.healthy.org.hk https://www.hongkong.org.hk https://www.lohas.org.hk https://www.funding.org.hk https://www.tvp.org.hk https://www.bud.org.hk https://www.smefund.org.hk https://news.business138.com https://news.corporate138.com https://news.company138.com https://news.product138.com https://news.service138.com https://news.solution138.com https://news.website138.com https://news.supplier138.com https://news.vendor138.com https://news.directory138.com https://news.business228.com https:

Hong Kong Science Park: Healthy ecosystem cultivates powerful global collaboration

(English) A healthy ecosystem cultivates powerful global collaboration   BeiGene, a global commercial-stage biotech company, has entered a worldwide strategic collaboration with our park company InnoRNA to take mRNA-based therapeutics to the next level. bit.ly/3yW8S0f You probably heard about Messenger RNA (mRNA). It has been used in some of the leading COVID vaccines. Q: What's mRNA's superpower? A: It directs human cells to generate proteins to help our immune systems develop antibodies for disease prevention and treatment. Q: What's InnoRNA's superpower? A: The platform developed by CEO Dr Li Linxian makes the mRNA less fragile, and the technology can rapidly and accurately identify safe and effective mRNA carriers for clinical treatment. Q: What's HKSTP's superpower? A: Hong Kong is the world's number two biotech funding hub.  We will leave you to find out more! Follow our page for more biotech news in Hong Kong and beyond. Reference : ht

HKSTP Park Company Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform

Congratulations! Eurekabio has raised an RMB 100M+ Series B round to advance its automated cell processing platform and the lentiviral vector production system developed by their team based at our Park.   Millions of people globally are suffering from different type of cancers. Our park company, Eurekabio, specialises in manufacturing supplies and platform for Cell and Gene Therapies (CGT).   Thank you Eurekabio for playing a pivotal role in accelerating the development of CGT through automation - Standardising cell processing procedures - Increasing efficiency - Reducing human error and contamination   Learn more: https://lnkd.in/gEGmc7Vz   Follow our page for more fundraising news happening in our thriving ecosystem. More Information : https://www.hkstp.org/what-we-offer/institute-for-translational-research-overview/